Learn More
Medchemexpress LLC Vortioxetine hydrobromide | 960203-27-4 | C18H23BrN2S | 500 MG

Supplier: Medchemexpress LLC HY15414A500MG
Vortioxetine hydrobromide is a multimodal serotonergic agent that acts as an antagonist for 5-HT3A and 5-HT7 receptors, an inhibitor of the 5-hydroxytryptamine transporter (SERT), a 5-HT1A agonist, and a partial 5-HT1B agonist. It is intended for research use.
- Antagonist for 5-HT3A and 5-HT7 receptors
- Inhibitor of 5-hydroxytryptamine transporter (SERT)
- Agonist for 5-HT1A receptors
- Partial agonist for 5-HT1B receptors
- Increases cell proliferation and survival
- Stimulates maturation of immature granule cells in hippocampus
- Does not cause cognitive or psychomotor impairment
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.